Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...
FinThrive, Inc., a healthcare revenue management software-as-a-service (SaaS) provider, and the Healthcare Information and Management Systems Society (HIMSS) today revealed the results of its recent ...
Nasopharyngeal Cancer Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
The design facilitates direct conjugate matching of the antenna and rectifier circuit, minimizing insertion losses and enabling a compact, fully integrated form factor. This configuration provides ...
“This collaboration represents the next wave of investigational targeted combinations with the potential to transform treatment options for people living with cancer,” said Pfizer oncology early stage ...
Dosing underway in INLIGHT trial of WVE-007 in obesity with clinical data expected in 2H 2025; enrollment complete in first single dose ...
TwoStep Therapeutics Unveils Its Lead Tumor-Targeted Drug Conjugate and New Radiopharmaceutical Program at Debut Scientific ...
Ocean wave energy is immense, with a huge contribution to make to the clean energy transition. According to the International Energy Agency (IEA), ocean power generation needs to grow by 33 per ...
We will begin the MacroGenics fourth quarter and full year 2024 corporate progress and financial results conference call in ...
An antibody–toxin conjugate targeting CD47 linked to the bacterial toxin listeriolysin O for cancer immunotherapy. Nature Cancer , 2025; DOI: 10.1038/s43018-025-00919-0 Cite This Page : ...
Dosing underway in INLIGHT trial of WVE-007 in obesity with clinical data expected in 2H 2025; enrollment complete in first single dose cohort Multi-dosing ongoing in 200 mg cohort of RestorAATion-2 ...